An observational study in Coronary Bifurcation Lesion, sponsored by Meshalkin Research Institute of Pathology of Circulation. Recruiting at 1 site in Russia. Open to participants aged 18 Years to 100 Years. Per ClinicalTrials.gov, last updated 2019-03-11.
Sponsored by Meshalkin Research Institute of Pathology of Circulation · Observational
The IBS registry is an observational, multi-center, real-world registry of stenting in coronary bifurcation lesions that will collect information on procedures and outcomes from various participating centers.
The aim of this registry is to investigate long-term clinical results and predictors of adverse outcomes after PCI for coronary bifurcation lesions among various participating centers.
Patients with coronary bifurcation lesions, if they meets all the study inclusion criteria and none of the exclusion criteria, after signing the informed consent, they will underwent PCI according to the current standard of care and will be entered in the registry. Follow-up for all subjects will continue for 5 years.
Meshalkin Research Institute of Pathology of Circulation is the lead sponsor of 118 studies on the registry; 8 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients with coronary bifurcation lesion treated during PCI
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Patients who have undergone bifurcation coronary artery stenting.
Procedure: PCI of bifurcation lesions
Different approaches for treatment of bifurcation coronary artery disease.
Procedural success
Achievement of technical success and with no in-hospital major adverse cardiac events
Time frame: 1 day
Major Adverse Cardiac and Cerebrovascular Events
Death, myocardial infarction (MI), target vessel revascularization (TVR), or stroke.
Time frame: 6 months, 1 year, 3 years, 5 years
All cause mortality
All of the deaths that occur in a study group, regardless of the cause.
Time frame: 6 months, 1 year, 3 years, 5 years
Death from cardiac causes
All deaths will be assumed cardiovascular in nature unless a non-cardiovascular cause can be clearly provided (e.g. malignancy, trauma, and infection).
Time frame: 6 months, 1 year, 3 years, 5 years
Myocardial infarction
The presence of electrocardiography findings indicative of ischemia that were not related to the index procedure, as well as chest discomfort associated with creatinine kinase-myocardial band fraction or troponin-T/troponin I greater than the upper limit of normal.
Time frame: 6 months, 1 year, 3 years, 5 years
Target vessel revascularization
Repeat PCI of the lesion within 5 mm of stent deployment or bypass graft surgery of the target vessel.
Time frame: 6 months, 1 year, 3 years, 5 years
Stent thrombosis
Sudden occlusion of a stented coronary artery due to formation of thrombosis.According to the Academic Research Consortium was defined as definite, probable, or possible.
Time frame: 6 months, 1 year, 3 years, 5 years
Plan to share: No
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Meshalkin Research Institute of Pathology of Circulation →